Grand Rapids-based Grand River Aseptic Manufacturing has entered into an agreement with drugmaker Bavarian Nordic to fill and finish the Denmark based vaccine company’s smallpox/monkepox vaccine. In an effort to increase the domestic supply, the U.S. Department of Health and Human Services and the Biomedical Advance Research and Development Authority helped broker the deal.
GRAM recently completed the installation of two new fill lines, bringing its capacity to three. One of those lines is dedicated to manufacturing the smallpox/monkeypox vaccine, JYNNEOS
Tom Ross is President and CEO of GRAM. He said, “We are happy to play our part and are proud to be in a position to support Bavarian Nordic and the U.S. Government with the monkeypox outbreak response. GRAM is putting forth all efforts possible to accelerate the manufacturing of the vaccine.”
In 2020, the U.S. Department of Defense through Operation Warp Speed selected Grand River Aseptic Manufacturing to deliver Johnson & Johnson’s COVID-19 vaccine.
